PORTLAND, Ore.–(HSMN NewsFeed)–Calypte Biomedical Corporation (OTCBB:CBMC ), a developer, manufacturer and marketer of HIV diagnostic tests, announces changes to its board of directors. On September 16, 2009, Calypte reported that Julius R. Krevans, M…
Diagnostics, HIV/AIDS, Personnel
Calypte Biomedical

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Calypte Biomedical Announces Changes to its Board of Directors”
Leave a Comment